loader

revive therapeutics

LATEST ARTICLES
Revive Therapeutics Announces Strategic Expansion of Bucillamine Program Across Infectious Diseases, Defence and Biothreat Medical Countermeasures

Revive Therapeutics Announces Strategic Expansion of Bucillamine Program Across Infectious Diseases, Defence and Biothreat Medical Countermeasures

Revive Therapeutics Strengthens Bucillamine IP Portfolio with North American Patent Filings for Nerve Agent Exposure and Granted Canadian Patent for Infectious Diseases

Revive Therapeutics Strengthens Bucillamine IP Portfolio with North American Patent Filings for Nerve Agent Exposure and Granted Canadian Patent for Infectious Diseases

Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study

Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study

Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study

Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study

CSE Bulletin: MOC Eligibility Update

CSE Bulletin: MOC Eligibility Update

Revive Therapeutics Announces Closing of Second Tranche of Private Placement

Revive Therapeutics Announces Closing of Second Tranche of Private Placement

Revive Therapeutics Announces Extension of Proposed Private Placement

Revive Therapeutics Announces Extension of Proposed Private Placement

Revive Provides Dial-In Information for Annual and Special Meeting

Revive Therapeutics Announces Successful Research Results for Psilocybin to Treat Traumatic Brain Injury and Filing of International Patent Application

IIROC Trade Resumption - RVV

IIROC Trading Halt - RVV

Latest News

More News

Outlook Reports world

Resource
Tech
Life Science

Browse Companies

Resource
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES